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nvestigation of pandemic inﬂuenza A (H1N1) 2009 virus:
solation and genetic analysis of brazilian strains
. Paiva
Instituto Adolfo Lutz, São Paulo, Brazil
Background: Since April 2009, human cases of respiratory
nfections originated by novel swine-origin inﬂuenza A virus,
esignated pandemic A(H1N1)v, have been detected world-
ide, causing immediate international concern. In Brazil,
s of 06 October 2009, there have been 14.229 conﬁrmed
ases of infection and 1.167 deaths. Mortality rates of
.61/100.000 inhabitantes were observed.
Methods: The virus samples were obtained from clin-
cal specimens from patients who came from the states
f São Paulo, Mato Grosso and Distrito Federal. Virus iso-
ation was performed in MDCK cell cultures. Viral RNA
as extracted from the infected cells and submitted to
everse transcription-ampliﬁcation reactions with primers
et designed to cover the complete segments of the HA,
A and MP genes. The ampliﬁed products were directed
equenced. The complete genes of hemagglutin (HA), neu-
aminidase (NA) and matrix (MP) were sequenced.
Results: Comparative sequence analysis indicated the
resence of point mutations in the HA gene of the
razilian strains when compared to the reference strain
/California/04/H1N1 (2009). These alterations do not
hange the all ﬁve of the known antigenic sites of the HA
rotein. The canonical sites for N-linked glycosylation at
xS/T motifs were preserved among strains. Data of the MP
equence analysis revealed that the strains of this study car-
ied the S31N mutation that confers cross-resistence to the
damantine class of anti-inﬂuenza drugs. Sequencing of the
A gene showed that the neuraminidase relative drug bind-
ng pocket represented by H275 was not altered, yielding
he strains sensitive to oseltamivir.
Conclusion: These results emphasize the contribution of
olecular surveillance, in addition to antigenic characteri-
ation to monitor the evolutionary pattern of the pandemic
(H1N1)v, in order to vaccine development, and evaluation
f antiviral drugs susceptibility.
oi:10.1016/j.ijid.2010.02.1690
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n analysis of critically ill patients with the novel
nﬂuenza A (H1N1) virus in Japan
. Wada1,∗, H. Nishiura2, A. Kawana3
Kitasato University School of Medicine, Sagamihara, Japan
PRESTO, Japan Science and Technology Agency, Saitama,
apan
National Defense Medical College, Saitama, Japan
Background: Japan identiﬁed its ﬁrst case of novel
nﬂuenza A (H1N1) on 9 May 2009, and its incidence has
ncreased steadily. As of 26 October, 34 deaths have been
eported. The aim of this study was to summarize the clinical
ndings of critically ill patients in Japan.
Methods: Critically ill patients are deﬁned as conﬁrmed
r probable cases who meet one of the following conditions:
P
5
oternational Congress on Infectious Diseases (ICID) Abstracts
case who (1) was diagnosed with inﬂuenza-associated
ncephalopathy, (2) was admitted to an intensive care unit
ICU), (3) was intubated or (4) died. We analyzed a total of
20 cases, including 23 deaths, who developed the disease
y 6 October 2009.
Results: Of the 120 cases, those aged < 20 years
ccounted for 71.7%. All 11 cases aged 65 and older resulted
n death, while the proportion of deaths among cases aged
20 years and adults aged < 65 years was smaller (5.2% and
4.8%, respectively). The mean (SD) and median times from
nset to hospitalization were 62.8 (40.2) and 48.0 hours,
espectively. The mean (SD) and median times from onset
o death for the 23 fatal cases were 160.4 (116.5) and
20.0 hours, respectively. The timing of antiviral administra-
ion did not appear to signiﬁcantly affect the clinical course
mong critically ill patients.
Of the 120 cases, 57 (47.5%) had at least one underly-
ng medical condition. Of the 86 cases aged < 20 years, 27
31.4%) had one or more comorbidity, with asthma being the
ost common (22.9%). Similarly, of the 34 adult cases, 30
88.2%) had comorbidities and chronic respiratory disease
23.5%) was the most common.
Conclusion: First, age below 20 were more frequently
eported as critically ill than adults. As the epidemic pro-
resses further, the age-composition of severe cases may
hange. Second, the clinical courses appeared to have been
apid after onset. The time from onset to death in Japan
as shorter than those reported elsewhere. Third, approxi-
ately half of the cases were accompanied by at least one
nderlying condition, and this proportion was particularly
igh among adults.
oi:10.1016/j.ijid.2010.02.1691
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linical, radiological features and outcome in children
ith conﬁrmed infection by 2009 inﬂuenza A H1N1,
dmitted to a reference hospital of Curitiba, Brazillian
outh region
. Giamberardino1,∗, L.F. Bricks2, V.H. Costa Jr.1, P.F.A.
oze1, F.A. Motta1, A.P.P. Oliveira3, M. Guedes1
Hospital Pequeno Principe, Curitiba, Brazil
Sanoﬁ Pasteur, São Paulo, Brazil
Hospital Pequeno Principe, Curitiba, Brazil
Background: Since 16 July, when pandemic 2009 A H1N1
irus was considered widespread in Brazil, a substantial
umber of children with acute respiratory symptoms (ARS)
emandedmedical services. The impact of this outbreak was
igniﬁcant; especially in Parana, São Paulo and Rio Grande
o Sul states (South region).We describe clinical and radi-
logical characteristics of 32 children attended at Hospital
equeno Principe,a pediatric reference center.
Methods: After review medical charts from 133 children
ttended because of ARS, from 24 July till 16 Oct, we
ollected data from 32 patients hospitalized for at least
4 hours because of inﬂuenza-like illness, and who had rRT-
CR positive test for 2009 A H1N1 inﬂuenza virus.
Results: The median age was 4.05y (range, 3m-14y1m):
1.61% were < 5 y, and 54.83% males. All patients received
seltamivir, on average 2.25 days (range 1— 22d) after the
